Helping Protect Patients and Staff on the COVID front lines
Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®) Designed for
- Diagnostic, Treatment and Transition areas
- Aerosol-generating procedures
- ICU’s, ED’s L&D
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087

Call Now to learn more about our solution the Illuvia® HUAIRS
+1 888 978 7087
Elevated bacterial content in OR air causes increased surgical site infection rates.
Prospective randomized multicenter study results shows that joint replacement procedures performed in rooms with over 50 CFU/m³ airborne bacterial colony forming units per cubic meter were 2.6 times as likely to have postoperative SSI than those done in cleaner air with 20 CFU/m³.
– OM LIDWELL, JOURNAL OF HOSPITAL INFECTION
Keeping Hospitals Safe
Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®)
Hospital air is contaminated with airborne microbes which can cause dangerous surgical site infections. Learn how the Illuvia® system is keeping patients safe.
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087
News and Events

Aerobiotix welcomes Aerobiovac, the Exclusive Distributor for Canada

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix, Inc. Announces Strategic Partnership with APIC

WHIO 7 Report: Improved Airborne Environments with the Illuvia HUAIRS

The Results are in… The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2

Montgomery Co. Common Pleas Court acquires air cleaning systems

Aerobiotix Partners with Surgery Center of Fort Lauderdale Clean Air Initiative

Aerobiotix joins Clean Hospitals, a Healthcare Environmental Hygiene Network

Aerobiotix partners with Battelle to perform SARS-CoV-2 bioaerosol elimination testing

Minnesota Orthopedic Center using Illuvia HUAIRS® to kill viruses in operating rooms as elective procedures resume.

Illuvia Installed Alexandrovska University Hospital, Bulgaria

Dr. Kirschman Letter on Coronavirus
News and Events

Aerobiotix welcomes Aerobiovac, the Exclusive Distributor for Canada

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix, Inc. Announces Strategic Partnership with APIC

WHIO 7 Report: Improved Airborne Environments with the Illuvia HUAIRS

The Results are in… The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2

Montgomery Co. Common Pleas Court acquires air cleaning systems

Aerobiotix Partners with Surgery Center of Fort Lauderdale Clean Air Initiative

Aerobiotix joins Clean Hospitals, a Healthcare Environmental Hygiene Network

Aerobiotix partners with Battelle to perform SARS-CoV-2 bioaerosol elimination testing

Minnesota Orthopedic Center using Illuvia HUAIRS® to kill viruses in operating rooms as elective procedures resume.

Illuvia Installed Alexandrovska University Hospital, Bulgaria

Dr. Kirschman Letter on Coronavirus
CLEANER AIR MEANS BETTER HEALTHCARE
Surgical site infections (SSIs) continue to constitute a significant fraction of hospital-acquired infections contributing to morbidity and mortality to healthcare systems globally. There are approximately 290,000 incidences of SSIs in the USA alone each year, translating into economic loss of $8.36 billion. A significant portion of SSIs have been proven to be airborne in origin and correlate with increased bacterial air content.
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087

The International Consensus Meeting on Musculoskeletal Infection is the definitive meeting of global leaders in orthopedic infection. Chaired by Dr. Javad Parvizi, the latest meeting was July 2018 in Philadelphia and attended by over 400 delegates.
By a 94% consensus, these leaders stated that: “the amount of airborne contamination in the active operating room should be minimized to prevent surgical site infection/PJI.” Only Illuvia HUAIRS is designed to reduce the possibility of surgical infections by decontaminating intraoperative air with a combination of advanced ultraviolet and HEPA technologies.